Literature DB >> 25469290

Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells.

Karina Galoian1, Amir Qureshi1, Gina Wideroff1, H T Temple2.   

Abstract

Disruption of cell-cell junctions and the concomitant loss of polarity, downregulation of tumor-suppressive adherens junctions and desmosomes represent hallmark phenotypes for several different cancer cells. Moreover, a variety of evidence supports the argument that these two common phenotypes of cancer cells directly contribute to tumorigenesis. In this study, we aimed to determine the status of intercellular junction proteins expression in JJ012 human malignant chondrosarcoma cells and investigate the effect of the antitumorigenic cytokine, proline-rich polypeptide-1 (PRP-1) on their expression. The cell junction pathway array data indicated downregulation of desmosomal proteins, such as desmoglein (1,428-fold), desmoplakin (620-fold) and plakoglobin (442-fold). The tight junction proteins claudin 11 and E-cadherin were also downregulated (399- and 52-fold, respectively). Among the upregulated proteins were the characteristic for tumors gap junction β-5 protein (connexin 31.1) and the pro-inflammatory pathway protein intercellular adhesion molecule (upregulated 129- and 43-fold, respectively). We demonstrated that PRP-1 restored the expression of the abovementioned downregulated in chondrosarcoma desmosomal proteins. PRP-1 inhibited H3K9-specific histone demethylase activity in chondrosarcoma cells in a dose-dependent manner (0.5 µg/ml PRP, 63%; 1 µg/ml PRP, 74%; and 10 µg/ml PRP, 91% inhibition). Members of the H3K9 family were shown to transcriptionally repress tumor suppressor genes and contribute to cancer progression. Our experimental data indicated that PRP-1 restores tumor suppressor desmosomal protein expression in JJ012 human chondrosarcoma cells and inhibits H3K9 demethylase activity, contributing to the suppression of tumorigenic potential in chondrosarcoma cells.

Entities:  

Keywords:  H3K9-specific histone demethylase; cell-cell adhesion; chondrosarcoma; desmosomal proteins; proline-rich polypeptide-1

Year:  2014        PMID: 25469290      PMCID: PMC4251108          DOI: 10.3892/mco.2014.445

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  34 in total

Review 1.  The desmosome.

Authors:  Emmanuella Delva; Dana K Tucker; Andrew P Kowalczyk
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

2.  mTORC1 inhibition and ECM-cell adhesion-independent drug resistance via PI3K-AKT and PI3K-RAS-MAPK feedback loops.

Authors:  Karina Galoian; H T Temple; Armen Galoyan
Journal:  Tumour Biol       Date:  2012-01-14

3.  Role of ICAM1 in invasion of human breast cancer cells.

Authors:  Caridad Rosette; Richard B Roth; Paul Oeth; Andreas Braun; Stefan Kammerer; Jonas Ekblom; Mikhail F Denissenko
Journal:  Carcinogenesis       Date:  2005-03-17       Impact factor: 4.944

4.  Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms.

Authors:  Taofei Yin; Spiro Getsios; Reto Caldelari; Andrew P Kowalczyk; Eliane J Müller; Jonathan C R Jones; Kathleen J Green
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

5.  Mispolarization of desmosomal proteins and altered intercellular adhesion in autosomal dominant polycystic kidney disease.

Authors:  Melina Silberberg; Audra J Charron; Robert Bacallao; Angela Wandinger-Ness
Journal:  Am J Physiol Renal Physiol       Date:  2005-02-08

Review 6.  Mesenchymal to epithelial transition in sarcomas.

Authors:  Jilong Yang; Xiaoling Du; Guowen Wang; Yan Sun; Kexin Chen; Xiongzeng Zhu; Alexander J F Lazar; Kelly K Hunt; Raphael E Pollock; Wei Zhang
Journal:  Eur J Cancer       Date:  2013-11-28       Impact factor: 9.162

7.  Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.

Authors:  Karina Galoian; Sean Scully; George McNamara; Patrick Flynn; Armen Galoyan
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 8.  Downregulation of gap junctions in cancer cells.

Authors:  Edward Leithe; Solveig Sirnes; Yasufumi Omori; Edgar Rivedal
Journal:  Crit Rev Oncog       Date:  2006-12

9.  Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.

Authors:  Linlin Yang; Yuan Chen; Tiantian Cui; Thomas Knösel; Qing Zhang; Kai Frederik Albring; Otmar Huber; Iver Petersen
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

10.  Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.

Authors:  Ingunn Holen; Jacob Whitworth; Faith Nutter; Alyson Evans; Hannah K Brown; Diane V Lefley; Ivana Barbaric; Mark Jones; Penelope D Ottewell
Journal:  Breast Cancer Res       Date:  2012-05-25       Impact factor: 6.466

View more
  10 in total

1.  Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.

Authors:  Karina Galoian; Shihua Luo; Amir Qureshi; Parthik Patel; Rachel Price; Ashlyn S Morse; Gor Chailyan; Silva Abrahamyan; H T Temple
Journal:  Mol Clin Oncol       Date:  2016-09-02

2.  Epigenetic control of cancer by neuropeptides.

Authors:  Karina Galoian; Parthik Patel
Journal:  Biomed Rep       Date:  2016-11-08

Review 3.  Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology.

Authors:  Gabriela Lupușoru; Ioana Ailincăi; Georgiana Frățilă; Oana Ungureanu; Andreea Andronesi; Mircea Lupușoru; Mihaela Banu; Ileana Văcăroiu; Constantin Dina; Ioanel Sinescu
Journal:  Biomedicines       Date:  2022-04-28

4.  Role of protein kinase N2 (PKN2) in cigarette smoke-mediated oncogenic transformation of oral cells.

Authors:  Pavithra Rajagopalan; Vishalakshi Nanjappa; Krishna Patel; Ankit P Jain; Kiran K Mangalaparthi; Arun H Patil; Bipin Nair; Premendu P Mathur; T S Keshava Prasad; Joseph A Califano; David Sidransky; Harsha Gowda; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2018-02-26       Impact factor: 5.782

5.  Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.

Authors:  Karina Galoian; Amir Qureshi; Gianluca D'Ippolito; Paul C Schiller; Marco Molinari; Andrea L Johnstone; Shaun P Brothers; Ana C Paz; H T Temple
Journal:  Int J Oncol       Date:  2015-06-18       Impact factor: 5.650

6.  Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.

Authors:  Karina Galoian; Silva Abrahamyan; Gor Chailyan; Amir Qureshi; Parthik Patel; Gil Metser; Alexandra Moran; Inesa Sahakyan; Narine Tumasyan; Albert Lee; Tigran Davtyan; Samvel Chailyan; Armen Galoyan
Journal:  Int J Oncol       Date:  2017-11-09       Impact factor: 5.650

7.  PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.

Authors:  A K Hoyt; A Moran; C Granger; A Sedani; S Saigh; J Brown; K A Galoian
Journal:  Oncol Rep       Date:  2019-05-24       Impact factor: 3.906

8.  Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.

Authors:  Caroline J Granger; Aaron K Hoyt; Alexandra Moran; Beatrice Becker; Anil Sedani; Shannon Saigh; Sheila A Conway; Jeffrey Brown; Karina Galoian
Journal:  Mol Med Rep       Date:  2020-09-02       Impact factor: 2.952

9.  Morpho‑functional study of the hypothalamic proline‑rich polypeptide apoptotic activity against mouse Ehrlich ascites carcinoma.

Authors:  S Abrahamyan; I Sahakyan; N Tumasyan; N Kocharyan; A Simonyan; R Aroutiounian; G Chailyan; S Chailyan; T Davtyan; K Galoian
Journal:  Oncol Rep       Date:  2020-05-04       Impact factor: 3.906

Review 10.  Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis.

Authors:  Ewa Nowak; Ilona Bednarek
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.